Versartis.com

Versartis. Nhận được giấy chứng nhận hợp pháp từ Curacao, đảm bảo tính an toàn cho người chơi. Xem chi tiết về nhà cái…

What’s new on Versartis.com: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Versartis.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Versartis

Subscribe to related news

SuppVersity Science Round-Up Seconds: All About DHEA. Plus: In Practice - Supplementation Benefits & Dosages?
via suppversity.blogspot

A lack of libido appears - if at all - treatable w/ DHEA only in peri-menopausal women (Maggi. 2013; Pucchino. 2013); there are however a lot of other things DHEA can do for you. The power of electricity made it possible. Yesterday's show went really...
Where are we now with Gene Therapy?
via totalbiopharma

Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. If a mutated gene causes a necessary protein to be faulty or missing, gene therapy may be able to introduce a normal copy...
Deals of the Week Looks at Ultra-Orphan Drug Pricing
via invivoblog.blogspot

In the first half of 2013, two drugs will have launched in the US priced at $250,000 per patient annually: Both address serious, ultra-rare diseases and are backed by KOLs and patients. But the similarities stop there. Three months into its launch, one...
BI-836845 a fully human mAb targeting IGF-1 created using HuCAL technology from Morphosys, for the potential iv infusion...
via newdrugapprovals.wordpress

BI-836845 Human monoclonal IgG1 lambda antibody against IGF-1 (insulin growth factor-1) and IGF-2 IGF pathway modulator (iv, cancer), Boehringer Ingelheim; Phase 2 Clinical Anticancer protein kinase inhibitor; Anticancer monoclonal antibody WO...
InPlay from Briefing.com
via whotrades.olanola

------ Major European indices trade lower across the board with Germany's DAX (-2.0%) trailing the region. Elsewhere, European Central Bank member Benoit Coeure said that debt relief for Greece is no longer a subject of debate with bailout negotiations...

Observe Versartis.com news and updates

Manager/Senior Manager, Finance and Accounting

Summary of Position: The successful candidate will be remotely based from the San Diego, CA area or located in our Morrisville, NC office. You will have responsibility over a combination of financial accounting/reporting and financial planning/analysis...
Peter Ho, M.D., Ph.D.

Peter Ho, M.D., Ph.D. Director Dr. Ho has served as a member of the Board of Directors since May 2021. Dr. Ho has more than 25 years of biotechnology and pharmaceutical industry experience in numerous operational roles. Dr. Ho served as the Chief Medical...
John Hohneker, M.D.

John Hohneker, M.D. Director Dr. Hohneker has served as a member of the Board of Directors since May 2021. Dr. Hohneker has 30 years of drug development and leadership experience within the biotech and pharmaceutical industry. Dr. Hohneker served as...
Sigurd Kirk

Sigurd Kirk Director Mr. Kirk has served as a member of the Board of Directors since May 2021. Mr. Kirk is a senior corporate business development executive with more than 15 years of pharmaceutical experience in the areas of branded biopharmaceutical...
Jody Gould

Jody Gould, Ph.D. Vice President of Regulatory Jody Gould, Ph.D. has nearly 30 years of broad experience and expertise in regulatory affairs strategy, management and policy and has supported all stages of drug and biological product development. She...

Versartis.com popular pages

Careers – Versartis Inc

be a company with a heart – Jay P. Shepard, President and CEO Empowered Employees. Innovation Without Boundaries. Meaningful Work. At Versartis, we are driven each day by our focus on patients who des...
Opportunities – Versartis Inc

If you are a motivated, hardworking person seeking to grow your career in the biotechnology industry while also making a meaningful difference for patients, we’d love to hear from you. The great thing...

J14VR5 Trial – Versartis Inc

J14VR5 Trial J14VR5 is a randomized, Phase 2/3, open-label, multi-center study of the pharmacokinetics (PK), pharmacodynamics (PD), safety and efficacy of a long-acting human growth hormone, somavarat...